Canopy Growth Corp (TSE:WEED - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as C$14.02 and last traded at C$14.67, with a volume of 9523051 shares. The stock had previously closed at C$11.32.
Analyst Ratings Changes
Several analysts recently weighed in on the stock. Sanford C. Bernstein lifted their price objective on shares of Canopy Growth from C$1.49 to C$6.70 in a research report on Tuesday, January 30th. Bank of America dropped their price target on shares of Canopy Growth from C$7.00 to C$4.00 in a research report on Wednesday, February 14th. Finally, Jefferies Financial Group dropped their price target on shares of Canopy Growth from C$7.28 to C$4.90 and set a "hold" rating on the stock in a research report on Tuesday, February 27th.
Check Out Our Latest Report on Canopy Growth
Canopy Growth Price Performance
The stock's 50-day moving average is C$6.00 and its 200-day moving average is C$3.66. The firm has a market cap of C$1.34 billion, a P/E ratio of -0.69, a price-to-earnings-growth ratio of -0.01 and a beta of 1.63. The company has a quick ratio of 2.32, a current ratio of 1.79 and a debt-to-equity ratio of 127.28.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Recommended Stories
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
